July 30, 2021 - ROSEN LOGO.jpg
YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YMAB
February 21, 2023 11:32 ET | The Rosen Law Firm PA
NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October...
SHAREHOLDER ALERT:  Barrack, Rodos & Bacine Encourages Y-mAbs Therapeutics Inc. (YMAB) Shareholders to Contact the Firm About a Recently Filed Securities Class Action Lawsuit
January 23, 2023 09:30 ET | Barrack Rodos & Bacine
PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine notifies investors that a securities class action lawsuit has been filed on behalf of purchasers of the common stock of...
Block & Leviton LLP Logo
Y-mAbs Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
October 26, 2022 14:53 ET | Block & Leviton LLP
BOSTON , Oct. 26, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) for potential securities law violations. Investors who have lost money in...